AI Insight
Schizophrenia and psychotic disorders represent a spectrum of severe mental conditions characterized by symptoms such as hallucinations, thought disorders, and cognitive impairment. These conditions affect approximately 3.89 per 1000 people globally, with an estimated 23.6 million cases of schizophrenia worldwide. The announcement of the Lancet Commission on schizophrenia and psychotic disorders signals a formal effort to address these conditions as a major unmet need in global health.
Why it matters
Establishing a dedicated commission signals institutional recognition of the gap between current care and patient needs for one of psychiatry's most debilitating condition groups. This initiative has the potential to produce evidence-based recommendations that could reshape global mental health policy and clinical practice.
Schizophrenia represents the severe end of a spectrum of psychotic disorders, including substance-induced conditions, characterised by psychotic symptoms (eg, hallucinations, formal and content-related thought disorder, and self-disorders) and frequently associated with cognitive impairment.1 These mental disorders remain among the most complex and debilitating unmet needs in global health.1,2 Psychotic disorders affect approximately 3·89 per 1000 people (pooled median point prevalence),3 and there are about 23·6 million cases of schizophrenia alone worldwide.
Source: [Comment] Announcing the Lancet Commission on schizophrenia and psychotic disorders